1980
Started dispensing pharmacy business with founding philosophy:
“Achieving True Separation of Drug Prescribing and Dispensing Services”
Anticipating the times and boldly embracing challenges.
Since its founding, Nihon Chouzai has grown by taking initiative in breaking new ground.
・Quality
・Flexibility
・Pioneer
We have evolved into a unique business portfolio by leveraging our expertise in the dispensing pharmacy business and expanding our commitment to healthcare.
2023
As a healthcare group giving people
the closest possible support,
we do everything in our power to
positively impact all aspects of society.
-
CEO Messages
（258KB）
-
Financial Strategy
（76KB）
-
Revision of the Long-Term Vision
（55KB）
- Amid dramatic changes in our business environment, we have begun exploring the formulation of a new long-term vision to achieve further growth.
I am committed to enhancing
corporate value from a long-term
perspective as a representative of a
wide range of stakeholders.
Mikiharu Noma Outside Director
Dialogue With
Outside Director
-
Dialogue With Outside Director
（822KB）
NIHON CHOUZAI will utilize its capital to address social issues through its business and make a wide-ranging contribution to healthcare in Japan.
To give people the closest possible support
-
Value Creation Process
（202KB）
280.1Billion yen
85%(as of July 2023)
14.6Billion yen
97%
(twelve or more visit per year,
as of September 2023）
A leading company in the pharmacy sector
Japan Medical Research Institute, Inc.
* Information Provision and Consulting Business results are included in
the Dispensing Pharmacy Business segment.
Supporting customers through
four businesses based on medical big data
Providing high value-added information and services
Nihon Generic Co., Ltd., Choseido Pharmaceutical Co., Ltd.
38.5Billion yen
564
(including two over-the-counter drugs)
Δ1.3Billion yen
5plants1laboratory
A manufacturer of a full line of generic drugs
8Billion yen
0.7Billion yen
An HR services company specializing in professionals in healthcare fields
-
Integrated Report（PDF）Download All Pages
（8,181KB）
-
Introduction
（1,328KB）
-
Introduction
（446KB）
-
Contents
（173KB）
-
Long-Term Results
（609KB）
-
Our Mission
（219KB）
-
Top Message
（1,080KB）
-
CEO Messages
（258KB）
-
Dialogue With Outside Director
（822KB）
-
Financial Strategy
（76KB）
-
Revision of the LongTerm Vision
（55KB）
-
How we create value
（3,685KB）
-
Value Creation Process
（202KB）
-
Stakeholder Engagement
（71KB）
-
Key Risks and Opportunities Projected in Carrying Out the Long-term Vision
（60KB）
-
Business Portfolio
（493KB）
-
At a glance
（60KB）
-
Digital Transformation Strategy
（116KB）
- ＜Business Overview＞
-
Dispensing Pharmacy Business
（1,302KB）
-
Information Provision and Consulting Business
（350KB）
-
Pharmaceutical Manufacturing and Sales Business
（581KB）
-
Medical Professional Staffing and Placement Business
（863KB）
-
Sustainability
（851KB）
-
Sustainability
（651KB）
-
Environment
（152KB）
-
HR Strategy
（131KB）
-
Corporate Governance
（755KB）
-
Corporate Governance
（95KB）
-
Message from Outside Directors
（403KB）
-
Board of Directors
（335KB）
-
Data
（92KB）
-
11-Year Summary of Financial and Non-Financial Data
（72KB）
-
Company Profile
（55KB）
